FibroBiologics reports FY results
Source: SeekingAlpha
2026-02-24 16:41:01 ET
More on FibroBiologics
- FibroBiologics granted extension by Nasdaq to regain compliance
- FibroBiologics announces $1.7M registered direct offering
- Seeking Alpha’s Quant Rating on FibroBiologics
- Historical earnings data for FibroBiologics
- Financial information for FibroBiologics
Read the full article on Seeking Alpha
For further details see:
FibroBiologics reports FY results
FibroBiologics Inc.
NASDAQ: FBLG
FBLG Trading
16.97% G/L:
$0.3294 Last:
856,745 Volume:
$0.30 Open:
FBLG Latest News
February 24, 2026 04:30:00 pm
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
FBLG Stock Data
$17,774,070
39,126,900
0.21%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
